Principal Investigator Dr. Mona Mashayekhi gave a talk at the Vanderbilt Digestive Diseases Research Center Retreat on April 16, 2025. Her presentation, “Immunologic Effects of GLP-1 Receptor Activation in Obesity,” explored how GLP-1 therapies may help reduce inflammation in people with obesity.